Circular Genomics at CTAD 2026

Nov 16–19, 2026 Boston, MA ~1.7k attendees Website

Circular Genomics takes part in 6 sessions at CTAD 2026 in Boston. Its program centres on circular RNA blood tests for Alzheimer's disease, from analytical performance to predicting who will progress. Its work tests the biomarkers across diverse groups and links them to disease pathways.

OrganizationCTAD 2026 Attendance
Circular Genomics
San Diego, California
◇Silver Sponsor
circulargenomics.com
Biomarker & diagnostics companiesSilver Sponsor
Develops blood tests based on brain-derived circular RNA to detect Alzheimer's disease and predict its progression.
Talk
Tue Nov 17
12:08pm
Poster
Wed Nov 18
7:15am–5:30pm
Poster
Wed Nov 18
7:15am–5:30pm
Poster
Wed Nov 18
7:15am–5:30pm
Poster
Wed Nov 18
7:15am–5:30pm
Poster
Wed Nov 18
7:15am–5:30pm

Explore the full CTAD 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full CTAD 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Circular Genomics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction